ANDA 85664, held by Watson Labs. Promethazine Hydrochloride.
As of Nov 16, 2026, ANDA 85664 (Promethazine Hydrochloride), held by Watson Labs, was not approved, with 1 approved supplement and 0 published complete response letters.
| Product | Active ingredient | Marketing |
|---|---|---|
| Promethazine Hydrochloride50MG ยท tablet;oral | Promethazine Hydrochloride | Discontinued |
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 13, 1986 | Supplement 4Manufacturing | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters